Group A Streptococcal bacteraemia. Experience at King Fahad Medical City in Riyadh, Saudi Arabia

Fawzyh J. Al-Khadidi, Mohammed A. AlSheheri, Tariq S. AlFawaz, Mushira A. Enani, Abdulaziz A. AlAqeel, Dayel A. AlShahrani

Abstract


Objectives: To identify clinical presentation, predisposing factors, and the outcome in patients with Group A Streptococcal bacteremia.

 

Methods: This is a retrospective study of 33 pediatric and adult patients with Streptococcus pyogenes bacteremia, admitted at King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia from 2007 to 2015.

 

Results: Thirty-three patient records, documenting bacteremia with group A beta-hemolytic streptococcus, were reviewed. Approximately 51.5% were pediatric and 48.5% were adult patients, with a male to female ratio of 2:1. The most frequently reported complications were renal impairment (45.5%) and acute respiratory distress (21.2%), followed by localized infection (15.2%), pleural effusion (6.1%), abscess (9.1%), necrotizing fasciitis (9.1%), septic arthritis, and osteomyelitis (3%). There were 10 episodes of shock: 6 were in pediatric and 4 were in adult patients. At the end of the study period, 12.1% patients died from the illness, 81.1% recovered from illness with no sequelae, while 6.1% recovered with sequelae. Mortality was observed in 4 patients; of them, 3 were pediatric patients and one was an adult with co-morbidities.

 

Conclusions: We have noted a minimal change in the disease pattern over the 28 years in Saudi Arabia. The management of invasive GAS infection depends on an accurate and timely diagnosis with an appropriate use of antimicrobial therapy. The highest risks appear to be related to chronic illness. Invasive Group A Streptococcal infection is known to have a high mortality rate.   


Saudi Med J 2017; Vol. 38 (10): 1034-1037
doi: 10.15537/smj.2017.10.20966


How to cite this article:
Al-Khadidi FJ, AlSheheri MA, AlFawaz TS, Enani MA, AlAqeel AA, AlShahrani DA. Group A Streptococcal bacteraemia. Experience at King Fahad Medical City in Riyadh, Saudi Arabia.  Saudi Med J. 2017 Oct;38(10):1034-1037. doi: 10.15537/smj.2017.10.20966.


Keywords


group A Streptococcus bacteremia; Streptococcus pyogenes; retrospective analysis; invasive infection, GAS

Full Text:

PDF HTML

References


O’Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM, et al. Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002; 35: 268-276.

Carapetis JR, editor. The Current Evidence for the Burden of Group A Streptococcal Diseases. Discussion papers on child health. Geneva: World Health Organization; 2004.

Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA 1993; 269: 384-389.

Ikebe T, Tominaga K, Shima T, Okuno R, Kubota H, Ogata K, et al. Increased prevalence of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2010 to 2012. Epidemiol Infect 2015; 143: 864-872.

Moses AE, Ziv A, Harari M, Rahav G, Shapiro M, Englehard D. Increased incidence and severity of Streptococcus pyogenes bacteremia in young children. Pediatr Infect Dis J 1995; 14: 767-770.

O’Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007; 45: 853-862.

Stockmann C, Ampofo K, Hersh AL, Blaschke AJ, Kendall BA, Korgenski K, et al. Evolving epidemiologic characteristics of invasive group a streptococcal disease in Utah, 2002-2010. Clin Infect Dis 2012; 55: 479-487.

Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998; 155: 264-271.

Svensson N, Oberg S, Henriques B, Holm S, Kallenius G, Romanus V, et al. Invasive Group A Streptococcal Infections in Sweden in 1994 and 1995: Epidemiology and Clinical Spectrum. Scand J Infect Dis 2000; 32: 609-614.

Al Majid F, Al Fawaz T, Buba F. Invasive Group A streptococcal bacteraemia: A comparative study at a Teaching Hospital in Riyadh, Saudi Arabia. Curr Pediatr Res 2008; 12: 49-52.

Lamagni TL, Neal S, Keshishian C, Powell D, Potz N, Pebody R, et al. Predictors of death after severe Streptococcus pyogenes infection. Emerg Infect Dis 2009; 15: 1304-1307.

AI Mazrou AM. Group A Streptococcal Bacteraemia: Experience at a University Hospital in Riyadh. Journal of Infection 1997; 34: 95-100.

Navarro VJ, Axelrod PI, Pinover W, Hockfield HS, Kostman JR. A comparison of streptococcus pyogenes (group a streptococcal) bacteremia at an urban and a suburban hospital: The importance of intravenous drug use. Arch Intern Med 1993; 153: 2679-2684.

Lentnek AL, Giger O, O’Rourke E. Group A beta-hemolytic streptococcal bacteremia and intravenous substance abuse. A growing clinical problem? Arch Intern Med 1990; 150: 89-93.

Holm SE, Norrby A, Bergholm AM, Norgren M. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis 1992; 166: 31-37.

Passaro DJ, Smitht DS, Hett EC, Reingold AL, Daily P, van Beneden CA, et al. Invasive group A streptococcal infections in the San Francisco Bay area, 1989-99. Epidemiol Infect 2002; 129: 471-478.

Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321: 1-7.

Chapnick EK, Gradon JD, Lutwick LI, Kim J, Levi M, Kim MH, et al. Streptococcal toxic shock syndrome due to noninvasive pharyngitis. Clin Infect Dis 1992; 14: 1074-1077.

Stevens DL. Streptococcal infections. Clin Infect Dis 1992; 14: 2-11.


Refbacks

  • There are currently no refbacks.




Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.